Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria

Summary: Background: The estimated incidence of colorectal cancer is rising in Nigeria, where most patients present with advanced disease. Earlier detection of colorectal cancer is a goal of the Nigerian National Cancer Control Plan, but the utility of fecal-based screening is unclear. This study a...

Full description

Bibliographic Details
Main Authors: Olusegun I Alatise, ProfMD, Anna J Dare, PhD, Patrick A Akinyemi, PhD, Fatimah B Abdulkareem, ProfMD, Samuel A Olatoke, MD, Gregory C Knapp, MD, T Peter Kingham, MD, Olusegun I. Alatise, MD, T. Peter Kingham, MD, Fatimah B Abdulkareem, MD, Samuel A. Olatoke, MD, Anna J. Dare, PhD, Patrick A. Akinyemi, PhD, Gregory C. Knapp, MD, Oluwabusayomi R. Ademakinwa, PhD, Ademola A. Adeyeye, MD, Olayide S. Agodirin, MD, Kabir B. Badmus, MD, Mathew O. Bojuwoye, MD, Matteo Di Bernardo, BA, Rivka Kahn, CCRP, Abdulrazzaq O. Lawal, MD, Emuobor A. Odeghe, MD, Samson G. Ogunleye, MSc, Olalekan O. Olasehinde, MD, Olajide T Olagboyega, MD, Christina Olcese, BS, Abdulfatai B. Olokoba, MD, Tosin Omoyiola, MD, Nnamdi O. Orah, MD, Adedapo O. Osinowo, MD, Ganiyat K. Oyeleke, MD, Israel A. Owoade, MD, Katherine Randolph, BA, Ranelle Tulloch, MPH
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X22001218